Recent News

By Category: Countermeasures

Pentagon Biodefense Initiative Seeks Successor to Antibiotics

(GSN Daily News) The U.S. Defense Department is seeking proposals for a system that incorporates nanotechnology to develop biological-weapon countermeasures within roughly one week, Wired magazine reported on Monday (see GSN, Jan. 20). The Defense Advanced Research Projects Agency’s

November 23, 2011
| Filed under North America, Biological Weapons, Countermeasures, and Research
Share

Darpa: Do Away With Antibiotics, Then Destroy All Pathogens

(Wired – Danger Room) Last year, federal officials warned that Americans were on the verge of “a post-antibiotic era.” And that’s exactly what the Pentagon’s far-out research agency is after. As long as they’ve got a replacement at the ready, of course. In the military’s latest round of small business solicitations, Darpa is making a Read More »

November 21, 2011
| Filed under North America, Biotechnology, Countermeasures, Policy & Initiatives, Public Health, and Research
Share

Need stressed for national biosafety framework

(DAWN.com) The conference titled “Building national biosafety and global ties” was the first international moot organised by the Pakistan Biological Safety Association (PBSA), a non-government organisation working to raise awareness about biosafety practices, …

November 21, 2011
| Filed under South Asia, Biosafety, Countermeasures, Policy & Initiatives, and Research
Share

Emergent BioSolutions Initiates Pivotal Clinical Trial Evaluating a Three-Dose BioThrax…

(Press release) EBS today announced the initiation of a pivotal immunogenicity and safety study to evaluate a three-dose vaccination schedule of BioThrax(R) (Anthrax Vaccine Adsorbed) for administration to individuals exposed to anthrax. Through this pivotal, licensure-enabling clinical study, the company seeks to obtain a post-exposure prophylaxis (PEP) indication for BioThrax. Approval of the PEP indication Read More »

November 18, 2011
| Filed under North America, Biotechnology, Countermeasures, Public Health, and Research
Share

PharmAthene to Present at the 2011 Chemical and Biological Defense Science and …

(Sacramento Bee) PharmAthene, Inc. announced today that data from its rPA anthrax vaccine and chemical nerve agent bioscavenger programs will be presented at the 2011 Chemical and Biological Defense Science and Technology …